Concordance‐discordance between apolipoprotein B and lipid biomarkers in predicting 20‐year atherosclerotic cardiovascular disease risk: The <scp>ATTICA</scp> study (2002–2022)
ApoB may be a superior biomarker for assessing long-term ASCVD risk, indicating that apoB-containing lipoprotein particle number, rather than cholesterol content, is a more robust predictor of ASCVD risk.
Authors
- Sofia‐Panagiota Giannakopoulou
- Petros Paul Sfikakis (ORCID: https://orcid.org/0000-0001-5484-2930)
- Fotios Barkas (ORCID: https://orcid.org/0000-0002-5940-6895)
- Christina A. Chrysohoou (ORCID: https://orcid.org/0000-0002-6340-3996)
- Smaragdi Antonopoulou (ORCID: https://orcid.org/0000-0002-7071-5920)
- Demosthenes B. Panagiotakos (ORCID: https://orcid.org/0000-0001-8583-153X)
- Evangelos Liberopoulos (ORCID: https://orcid.org/0000-0002-7162-3323)
- Costas Tsioufis
- C. Pitsavos
Institutions
- University of Ioannina (GR)
- National and Kapodistrian University of Athens (GR)
- Harokopio University of Athens (GR)
- Laiko General Hospital of Athens (GR)
- Hippocration General Hospital (GR)
Publication Details
- Journal
- European Journal of Clinical Investigation
- Published
- 2025-05-19
- DOI
- https://doi.org/10.1111/eci.70077
- Citations
- 3
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 6.02
Funders
- Hellenic Cardiological Society
- Hellenic Atherosclerosis Society